Clinical trial
Ventricular Pacing Site Selection (V-PASS)
NCT00292383 · Medtronic BRC, Industry · Unknown status
Key facts
| NCT number | NCT00292383 |
|---|---|
| Title | Ventricular Pacing Site Selection (V-PASS) |
| Official title | A Randomized, Prospective Multicenter Pilot Study to Determine the Influence of the Ventricular Pacing Site on the Incidence of Atrial Fibrillation and Heart Failure in Patients With Indication for Permanent Pacemaker Stimulation Therapy. |
| Lead sponsor | Medtronic BRC, Industry |
| Collaborators | Vitatron GmbH Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Atrioventricular Block |
| Intervention type | Procedure |
| Interventions | Leads to be implanted according randomization on specified sites. Vitatron pacemakers to be implanted: T60 DR, T70 DR, T20 SR, C60 DR |
| Enrollment | 100 |
| Completion | Dec 1, 2008 |
| First posted | Feb 15, 2006 |
| Last update posted | Aug 2, 2011 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: